Functional Role of Regulatory Lymphocytes in Stroke

Stroke

Volumn 46, Issue 5, 2015, Pages 1422-1430

  Liesz, Arthur ^a,b   Hu, Xiaoming ^c   Kleinschnitz, Christoph ^d   Offner, Halina ^e,f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Germany 3 Munich Cluster for Systems Neurology   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Neuroimmunology Research   (United States)

Author keywords

brain ischemia; inflammation; lymphocyte; models, animal; retaliatory T cells; stroke

Indexed keywords

CANCER GROWTH FACTOR; GAMMA INTERFERON; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 35; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SELECTIN; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CD122+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; META ANALYSIS (TOPIC); MICROTHROMBUS; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPERFUSION; REVIEW; T CELL DEPLETION; COMPLICATION; DRUG EFFECTS; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; STROKE;

BRAIN ISCHEMIA; HUMANS; INFLAMMATION; STROKE; T-LYMPHOCYTES, REGULATORY;

EID: 84937243004     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008608     Document Type: Review

References (82)

1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796-808. doi: 10.1038/nm.2399.
2. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15:946-950. doi: 10.1038/nm.1999.
3. Gelderblom M, Weymar A, Bernreuther C, Velden J, Arunachalam P, Steinbach K, et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. 2012;120:3793-3802. doi: 10.1182/blood-2012-02-412726.
4. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704-720.
5. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490-500. doi: 10.1038/nri2785.
6. Schäbitz WR. Regulatory T cells in ischemic stroke: helpful or hazardous? Stroke. 2013;44:e84. doi: 10.1161/STROKEAHA.113.002228.
7. Xu X, Li M, Jiang Y. The paradox role of regulatory T cells in ischemic stroke. Sci World J. 2013;2013:174373. doi: 10.1155/2013/174373.
8. Chen S, Wu H, Klebe D, Hong Y, Zhang J, Tang J. Regulatory T cell in stroke: a new paradigm for immune regulation. Clin Dev Immunol. 2013;2013:689827. doi: 10.1155/2013/689827.
9. Sakaguchi S. Regulatory T cells: key controllers of immunologic selftolerance. Cell. 2000;101:455-458.
10. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-1164.
11. Ochs HD, Ziegler SF, Torgerson TR. FOXP3 acts as a rheostat of the immune response. Immunol Rev. 2005;203:156-164. doi: 10.1111/j.0105-2896.2005.00231.x.
12. Baecher-Allan C, Anderson DE. Regulatory cells and human cancer. Semin Cancer Biol. 2006;16:98-105. doi: 10.1016/j.semcancer.2005.11.003.
13. Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005;116:949-959, quiz 960. doi: 10.1016/j.jaci.2005.08.047.
14. Battaglia M, Roncarolo MG. Induction of transplantation tolerance via regulatory T cells. Inflamm Allergy Drug Targets. 2006;5:157-165.
15. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med. 2006;354:1166-1176. doi: 10.1056/NEJMra055446.
16. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev. 2006;212:60-73. doi: 10.1111/j.0105-2896.2006.00415.x.
17. Schroeter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol. 1994;55:195-203.
18. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849-1857. doi: 10.1161/STROKEAHA.108.534503.
19. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15:192-199.
20. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N, et al. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol. 2013;23:34-44. doi: 10.1111/j.1750-3639.2012.00614.x.
21. Stubbe T, Ebner F, Richter D, Engel O, Randolf Engel O, Klehmet J, et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab. 2013;33:37-47. doi: 10.1038/jcbfm.2012.128.
22. Liesz A, Zhou W, Na SY, Hämmerling GJ, Garbi N, Karcher S, et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013;33:17350-17362. doi: 10.1523/JNEUROSCI.4901-12.2013.
23. Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Göbel K, Schuhmann MK, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679-691. doi: 10.1182/blood-2012-04-426734.
24. Xie L, Sun F, Wang J, Mao X, Xie L, Yang SH, et al. mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. J Immunol. 2014;192:6009-6019. doi: 10.4049/jimmunol.1303492.
25. Ren X, Akiyoshi K, Vandenbark AA, Hurn PD, Offner H. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis. 2011;26:87-90. doi: 10.1007/s11011-010-9226-6.
26. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann Neurol. 2013;74:458-471. doi: 10.1002/ana.23815.
27. Kleinschnitz C, Wiendl H. Con: regulatory T cells are protective in ischemic stroke. Stroke. 2013;44:e87-e88. doi: 10.1161/STROKEAHA.113.001268.
28. Hu X, Li P, Chen J. Pro: regulatory T cells are protective in ischemic stroke. Stroke. 2013;44:e85-e86. doi: 10.1161/STROKEAHA.113.001267.
29. Urra X, Cervera A, Villamor N, Planas AM, Chamorro A. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience. 2009;158:1174-1183. doi: 10.1016/j.neuroscience.2008.06.014.
30. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191-197. doi: 10.1038/ni1428.
31. Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, Garbi N, et al. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol. 2010;184:1810-1820. doi: 10.4049/jimmunol.0902420.
32. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. 2007;204:57-63. doi: 10.1084/jem.20061852.
33. Gee JM, Kalil A, Thullbery M, Becker KJ. Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke. 2008;39:1575-1582. doi: 10.1161/STROKEAHA.107.501486.
34. Ishibashi S, Maric D, Mou Y, Ohtani R, Ruetzler C, Hallenbeck JM. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2009;29:606-620. doi: 10.1038/jcbfm.2008.153.
35. Brea D, Agulla J, Rodríguez-Yáñez M, Barral D, Ramos-Cabrer P, Campos F, et al. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia. J Cell Mol Med. 2014;18:1571-1579. doi: 10.1111/jcmm.12304.
36. Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, et al. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad Sci U S A. 2003;100:15107-15112. doi: 10.1073/pnas.2436538100.
37. Li P, Mao L, Liu X, Gan Y, Zheng J, Thomson AW, et al. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke. Stroke. 2014;45:857-864. doi: 10.1161/STROKEAHA.113.004100.
38. Li P, Mao L, Zhou G, Leak RK, Sun BL, Chen J, et al. Adoptive regulatory T-cell therapy preserves systemic immune homeostasis after cerebral ischemia. Stroke. 2013;44:3509-3515. doi: 10.1161/STROKEAHA.113.002637.
39. Na SY, Mracsko E, Liesz A, Hünig T, Veltkamp R. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice. Stroke. 2015;46:212-220. doi: 10.1161/STROKEAHA.114.007756.
40. Schuhmann MK, Kraft P, Stoll G, Lorenz K, Meuth SG, Wiendl H, et al. CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. J Cereb Blood Flow Metab. 2015;35:6-10. doi: 10.1038/jcbfm.2014.175.
41. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;30:636-645. doi: 10.1016/j.immuni.2009.04.010.
42. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189-192.
43. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G, et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci. 2000;12:2265-2272.
44. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke. Metab Brain Dis. 2013;28:375-386. doi: 10.1007/s11011-013-9413-3.
45. Liesz A, Bauer A, Hoheisel JD, Veltkamp R. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study. Neurosci Lett. 2014;579:18-23. doi: 10.1016/j. neulet.2014.07.003.
46. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest. 2004;114:1372-1378. doi: 10.1172/JCI23215.
47. Frenkel D, Huang Z, Maron R, Koldzic DN, Hancock WW, Moskowitz MA, et al. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol. 2003;171:6549-6555.
48. Frenkel D, Huang Z, Maron R, Koldzic DN, Moskowitz MA, Weiner HL. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci. 2005;233:125-132. doi: 10.1016/j. jns.2005.03.022.
49. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, et al. Interleukin-10 in the brain. Crit Rev Immunol. 2001;21:427-449.
50. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J Neuroinflammation. 2013;10:111. doi: 10.1186/1742-2094-10-111.
51. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31:8556-8563. doi: 10.1523/JNEUROSCI.1623-11.2011.
52. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation. 2006;113:2105-2112. doi: 10.1161/CIRCULATIONAHA.105.593046.
53. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T, et al. Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood. 2010;115:3835-3842. doi: 10.1182/blood-2009-10-249078.
54. Offner H, Hurn PD. A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res. 2012;3:324-330. doi: 10.1007/s12975-012-0187-4.
55. Bodhankar S, Chen Y, Vandenbark AA, Murphy SJ, Offner H. Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice. Metab Brain Dis. 2014;29:59-73. doi: 10.1007/s11011-013-9474-3.
56. Chen Y, Bodhankar S, Murphy SJ, Vandenbark AA, Alkayed NJ, Offner H. Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice. Metab Brain Dis. 2012;27:487-493. doi: 10.1007/s11011-012-9317-7.
57. Bodhankar S, Chen Y, Lapato A, Vandenbark AA, Murphy SJ, Saugstad JA, et al. Regulatory CD8+CD122+ T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting b-cells [published online ahead of print December 25, 2014]. Metab Brain Dis. http://link.springer.com/article/10.1007/s11011-014-9639-8. Accessed February 26, 2015.
58. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26:654-665. doi: 10.1038/sj.jcbfm.9600217.
59. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775-786. doi: 10.1038/nrn1765.
60. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006;176:6523-6531.
61. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke. 2009;40:2849-2858. doi: 10.1161/STROKEAHA.109.549618.
62. Irmler IM, Gajda M, Kamradt T. Amelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function. Ann Rheum Dis. 2014;73:2183-2191. doi: 10.1136/annrheumdis-2013-204148.
63. Liesz A, Dalpke A, Mracsko E, Antoine DJ, Roth S, Zhou W, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci. 2015;35:583-598. doi: 10.1523/JNEUROSCI.2439-14.2015.
64. Wang J, Yu L, Jiang C, Fu X, Liu X, Wang M, et al. Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun. 2015;43:172-183. doi: 10.1016/j.bbi.2014.07.022.
65. Courties G, Herisson F, Sager H, Heidt T, Ye Y, Ying W, et al. Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res. 2015;116:407-417.
66. Hug A, Liesz A, Muerle B, Zhou W, Ehrenheim J, Lorenz A, et al. Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke. 2011;42:3580-3586. doi: 10.1161/STROKEAHA.111.620948.
67. Yan J, Read SJ, Henderson RD, Hull R, O'Sullivan JD, McCombe PA, et al. Frequency and function of regulatory T cells after ischaemic stroke in humans. J Neuroimmunol. 2012;243:89-94. doi: 10.1016/j. jneuroim.2011.12.019.
68. Li Q, Wang Y, Yu F, Wang YM, Zhang C, Hu C, et al. Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction. Int J Clin Exp Pathol. 2013;6:1015-1027.
69. Wigren M, Björkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol. 2012;32:2000-2004. doi: 10.1161/ATVBAHA.112.251579.
70. Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab. 2012;32:1310-1316. doi: 10.1038/jcbfm.2011.186.
71. Gauberti M, Martinez de Lizarrondo S, Orset C, Vivien D. Lack of secondary microthrombosis after thrombin-induced stroke in mice and nonhuman primates. J Thromb Haemost. 2014;12:409-414. doi: 10.1111/jth.12487.
72. Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401-410. doi: 10.1038/nrneurol.2012.98.
73. Liesz A, Rüger H, Purrucker J, Zorn M, Dalpke A, Möhlenbruch M, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One. 2013;8:e74839. doi: 10.1371/journal. pone.0074839.
74. Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab. 2014;34:450-459. doi: 10.1038/jcbfm.2013.217.
75. Levings MK, Allan S, d'Hennezel E, Piccirillo CA. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv Immunol. 2006;92:119-155. doi: 10.1016/S0065-2776(06)92003-3.
76. Danese S, Rutella S. The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity. Curr Med Chem. 2007;14:649-666.
77. Schwartz M, Raposo C. Protective autoimmunity: a unifying model for the immune network involved in CNS repair. Neuroscientist. 2014;20:343-358. doi: 10.1177/1073858413516799.
78. Walsh JT, Zheng J, Smirnov I, Lorenz U, Tung K, Kipnis J. Regulatory T cells in central nervous system injury: a double-edged sword. J Immunol. 2014;193:5013-5022. doi: 10.4049/jimmunol.1302401.
79. Kipnis J, Schwartz M. Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease. Neuromolecular Med. 2005;7:197-206. doi: 10.1385/NMM:7:3:197.
80. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A. 2002;99:15620-15625. doi: 10.1073/pnas.232565399.
81. Kimmelman J, Mogil JS, Dirnagl U. Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol. 2014;12:e1001863. doi: 10.1371/journal.pbio.1001863.
82. Dirnagl U, Hakim A, Macleod M, Fisher M, Howells D, Alan SM, et al. A concerted appeal for international cooperation in preclinical stroke research. Stroke. 2013;44:1754-1760. doi: 10.1161/STROKEAHA.113.000734.